Men are much less likely to get multiple sclerosis (MS) than women, and one reason is that they are protected by high levels of testosterone. Scientists have now discovered how it works. They have identified a guardian molecule — triggered by testosterone — that appears to protect males from disease. When female mice with disease are treated with this protective molecule, their symptoms were eliminated. The findings could lead to a new therapy for MS.Original Article
You may also like
New alloys for manufacturing freeze-dryers
Navigating the Complexities of Emerging Therapy...
INTERPHEX 2025: Preventing Spills in the Manufacturing...
Agentic AI Growth Predicted, but More Than Half of...
Microsoft and SkyCell Collaborate on Pharma Supply...
Siemens Acquires Dotmatics, Extending AI Software...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.
